ELVN Enliven Therapeutics, Inc. logo

ELVN Enliven Therapeutics, Inc.

Healthcare
$42.53+2.38%ClosedMarket Cap: $2.59B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

2

Dispositions

8

Buy/Sell Ratio

0.25

Net Shares

-10,000

Shares Acquired

10,000

Shares Disposed

20,000

Total Bought ($)

$0.00

Total Sold ($)

$6.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Wed May 20Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell3,475$39.5326,525
Wed May 20Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell1,302$40.2525,223
Wed May 20Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell223$41.2125,000
Wed May 20Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell5,000$2.48126,268
Tue Apr 21Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell2,441$48.0625,000
Tue Apr 21Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell2,419$47.3927,441
Tue Apr 21Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell140$45.8129,860
Tue Apr 21Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell5,000$2.48131,268
Fri Mar 27Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell40,000$35.1025,000
Fri Mar 27Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell40,000$2.48136,268
Thu Mar 19Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell5,000$27.7625,000
Thu Mar 19Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell5,000$2.48176,268
Wed Mar 11Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell29,871$30.0225,000
Wed Mar 11Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell10,129$30.1925,000
Wed Mar 11Collins Helen Louiseofficer: CHIEF MEDICAL OFFICERSell29,871$2.48191,397